Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study

MicroRNAs are a class of small, endogenous, noncoding 18- to 24-nucleotide-long RNAs that can regulate multiple processes related to cancer progression. However, their clinical value in patients with oral squamous cell carcinoma has not yet been fully explored. Therefore, the aim of this study was t...

Full description

Bibliographic Details
Main Authors: Hikaru Nakashima, Ryoji Yoshida, Akiyuki Hirosue, Kenta Kawahara, Junki Sakata, Hidetaka Arita, Tatsuro Yamamoto, Ryo Toya, Ryuji Murakami, Akimitsu Hiraki, Masanori Shinohara, Takaaki Ito, Yoshikazu Kuwahara, Hideki Nakayama
Format: Article
Language:English
Published: IOS Press 2019-03-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428319826853
_version_ 1818878526226432000
author Hikaru Nakashima
Ryoji Yoshida
Akiyuki Hirosue
Kenta Kawahara
Junki Sakata
Hidetaka Arita
Tatsuro Yamamoto
Ryo Toya
Ryuji Murakami
Akimitsu Hiraki
Masanori Shinohara
Takaaki Ito
Yoshikazu Kuwahara
Hideki Nakayama
author_facet Hikaru Nakashima
Ryoji Yoshida
Akiyuki Hirosue
Kenta Kawahara
Junki Sakata
Hidetaka Arita
Tatsuro Yamamoto
Ryo Toya
Ryuji Murakami
Akimitsu Hiraki
Masanori Shinohara
Takaaki Ito
Yoshikazu Kuwahara
Hideki Nakayama
author_sort Hikaru Nakashima
collection DOAJ
description MicroRNAs are a class of small, endogenous, noncoding 18- to 24-nucleotide-long RNAs that can regulate multiple processes related to cancer progression. However, their clinical value in patients with oral squamous cell carcinoma has not yet been fully explored. Therefore, the aim of this study was to investigate the clinical significance of circulating microRNAs in oral squamous cell carcinoma patients. The expression levels of circulating miR-1246 and miR-1290 in healthy volunteers and oral squamous cell carcinoma patients were examined by quantitative real-time polymerase chain reaction. The expression levels of both microRNAs in the radioresistant oral squamous cell carcinoma cell line (SAS-R) and the parent cell line (SAS) and in the conditioned medium obtained from these cell lines were also examined by quantitative real-time polymerase chain reaction. In addition, the correlations between circulating microRNA status and various clinicopathological features in 55 oral squamous cell carcinoma patients with locally advanced oral squamous cell carcinoma who underwent surgery following 5-fluorouracil-based chemoradiotherapy were examined. The expression level of miR-1290 was significantly lower in the plasma of oral squamous cell carcinoma patients than in that of healthy volunteers (p < 0.01). The expression levels of microRNAs in the conditioned medium and in the cells varied from cell to cell. In the clinicopathological analyses, the frequency of patients with low miR-1290 levels was significantly higher among cases with lower pathological differentiation and among those with a poor pathological response for preoperative chemoradiotherapy (p = 0.030 each). Furthermore, Cox regression analysis based on the 5-year overall survival and disease-free survival revealed that miR-1290 status was a significant prognostic factor for patients with oral squamous cell carcinoma (hazard ratio = 0.169, p = 0.008, and hazard ratio = 0.186, p = 0.008, respectively). Circulating miR-1290 status could be a valuable biomarker for predicting the clinical response to chemoradiotherapy as well as overall survival in patients with oral squamous cell carcinoma.
first_indexed 2024-12-19T14:15:35Z
format Article
id doaj.art-0d9d8e1510a04e60ba36b47d03ec10a5
institution Directory Open Access Journal
issn 1423-0380
language English
last_indexed 2024-12-19T14:15:35Z
publishDate 2019-03-01
publisher IOS Press
record_format Article
series Tumor Biology
spelling doaj.art-0d9d8e1510a04e60ba36b47d03ec10a52022-12-21T20:18:00ZengIOS PressTumor Biology1423-03802019-03-014110.1177/1010428319826853Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective studyHikaru Nakashima0Ryoji Yoshida1Akiyuki Hirosue2Kenta Kawahara3Junki Sakata4Hidetaka Arita5Tatsuro Yamamoto6Ryo Toya7Ryuji Murakami8Akimitsu Hiraki9Masanori Shinohara10Takaaki Ito11Yoshikazu Kuwahara12Hideki Nakayama13Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanDepartment of Radiation Oncology, Kumamoto University Hospital, Kumamoto, JapanDepartment of Medical Imaging, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanSection of Oral Oncology, Department of Oral and Maxillofacial Surgery, Fukuoka Dental College, Fukuoka, JapanItoh Dento-Maxillofacial Hospital, Kumamoto, JapanDepartment of Pathology and Experimental Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, JapanDivision of Radiation Biology and Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanMicroRNAs are a class of small, endogenous, noncoding 18- to 24-nucleotide-long RNAs that can regulate multiple processes related to cancer progression. However, their clinical value in patients with oral squamous cell carcinoma has not yet been fully explored. Therefore, the aim of this study was to investigate the clinical significance of circulating microRNAs in oral squamous cell carcinoma patients. The expression levels of circulating miR-1246 and miR-1290 in healthy volunteers and oral squamous cell carcinoma patients were examined by quantitative real-time polymerase chain reaction. The expression levels of both microRNAs in the radioresistant oral squamous cell carcinoma cell line (SAS-R) and the parent cell line (SAS) and in the conditioned medium obtained from these cell lines were also examined by quantitative real-time polymerase chain reaction. In addition, the correlations between circulating microRNA status and various clinicopathological features in 55 oral squamous cell carcinoma patients with locally advanced oral squamous cell carcinoma who underwent surgery following 5-fluorouracil-based chemoradiotherapy were examined. The expression level of miR-1290 was significantly lower in the plasma of oral squamous cell carcinoma patients than in that of healthy volunteers (p < 0.01). The expression levels of microRNAs in the conditioned medium and in the cells varied from cell to cell. In the clinicopathological analyses, the frequency of patients with low miR-1290 levels was significantly higher among cases with lower pathological differentiation and among those with a poor pathological response for preoperative chemoradiotherapy (p = 0.030 each). Furthermore, Cox regression analysis based on the 5-year overall survival and disease-free survival revealed that miR-1290 status was a significant prognostic factor for patients with oral squamous cell carcinoma (hazard ratio = 0.169, p = 0.008, and hazard ratio = 0.186, p = 0.008, respectively). Circulating miR-1290 status could be a valuable biomarker for predicting the clinical response to chemoradiotherapy as well as overall survival in patients with oral squamous cell carcinoma.https://doi.org/10.1177/1010428319826853
spellingShingle Hikaru Nakashima
Ryoji Yoshida
Akiyuki Hirosue
Kenta Kawahara
Junki Sakata
Hidetaka Arita
Tatsuro Yamamoto
Ryo Toya
Ryuji Murakami
Akimitsu Hiraki
Masanori Shinohara
Takaaki Ito
Yoshikazu Kuwahara
Hideki Nakayama
Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study
Tumor Biology
title Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study
title_full Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study
title_fullStr Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study
title_full_unstemmed Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study
title_short Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study
title_sort circulating mirna 1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma a single center retrospective study
url https://doi.org/10.1177/1010428319826853
work_keys_str_mv AT hikarunakashima circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy
AT ryojiyoshida circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy
AT akiyukihirosue circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy
AT kentakawahara circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy
AT junkisakata circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy
AT hidetakaarita circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy
AT tatsuroyamamoto circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy
AT ryotoya circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy
AT ryujimurakami circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy
AT akimitsuhiraki circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy
AT masanorishinohara circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy
AT takaakiito circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy
AT yoshikazukuwahara circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy
AT hidekinakayama circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy